ADVAXIS has a total of 14 patent applications. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are ADURO BIOTECH, SMITHKLINE BEECHAM BIOLOG S and GLAXOSMITHKLINE BIOLOG SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | China | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Canada | 2 | |
#5 | Brazil | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Climate change adaptation technologies | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Shahabi Vafa | 7 |
#2 | Rothman John | 5 |
#3 | Wallecha Anu | 3 |
#4 | Maciag Paulo | 2 |
#5 | Paterson Yvonne | 1 |
#6 | Singh Reshma | 1 |
#7 | Vafa Shahabi | 1 |
Publication | Filing date | Title |
---|---|---|
CA2845583A1 | Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors | |
CA2829960A1 | Listeria-based adjuvants | |
WO2011060260A2 | Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors | |
WO2009143167A2 | Dual delivery system for heterologous antigens |